Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
RRx-001, a novel epigenetic modulator: Resensitization to previously failed therapy in the ongoing phase 2 colorectal cancer study, ROCKET Reid, T., Fisher, G., Carter, C., Cho-Phan, C., Kunz, P., Oronsky, B., Fanger, G., Stirn, M., Caroen, S., Parker, C., Scicinski, J. AMER ASSOC CANCER RESEARCH. 2016
View details for DOI 10.1158/1538-7445.CHROMEPI15-B26
View details for Web of Science ID 000368930800036